Novavax | NVAX - Dochód Netto





Dochód Netto Zmiana Data
Adma Biologics USD 49.38M 12.95M 2025-12
Agenus USD -10.63M 74.49M 2025-12
AstraZeneca USD 2.33B 207M 2025-12
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
Cassava Sciences USD -12.54M 1.73M 2025-12
Geron USD -31.14M 12.72M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
MannKind USD -15.95M 23.93M 2025-12
Merck USD 2.96B 2.82B 2025-12
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Moderna USD -200M 625M 2025-09
Novartis USD 2.41B 1.52B 2025-12
Novavax USD 17.53M 219.91M 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
TG Therapeutics USD 23.04M 367.86M 2025-12